Does lGE provide Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis?
Diffuse LGE provides incremental prognosis over cardiac biomarker stage in patients with AL cardiac amyloidosis.
In a multiple regression model, lower HbA(1c) was significantly associated with better adolescent-rated QOL on all four subscales and with lower perceived family burden as assessed by parents and health professionals.